Board logo

subject: United States In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 [print this page]


Author: Aarkstore Enterprise
Author: Aarkstore Enterprise



United States In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the USA In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in the USA

Scope

- The report provides information on the US in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.

- Total revenues, end users

- Market shares of all the key competitors.

- Key pipeline products that are set to shape the market, broken down by sector.

- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.

- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

- Key mergers and acquisitions, partnerships, private equity investments and IPOs.

- Customer, hospitals and physicians data. F. Hoffmann-La Roche Ltd.

Siemens Healthcare

Sysmex Corporation

Abbott Laboratories

Beckman Coulter, Inc.

Ortho-Clinical Diagnostics Inc.

OLYMPUS CORPORATION

Qiagen N.V.

bioMerieux S.A.

Bio-Rad Laboratories, Inc.

Phadia AB

DiaSorin S.p.A

Becton, Dickinson and Company

Gen-Probe Incorporated

Inverness Medical Innovations, Inc.

Ventana Medical Systems, Inc.

Hologic, Inc.

Dade Behring Holdings, Inc.

Calypte Biomedical Corporation

CytoCore, Inc.

Daxor Corporation

IRIS International, Inc.

Meridian Bioscience, Inc.

Immucor, Inc.

Onconome, Inc.

Streck, Inc.

Targeted Diagnostics & Therapeutics, Inc.

Haemonetics Corporation

Bio-Med USA Inc.

Biomeda Corp.

Quidel Corporation

American Bio Medica Corporation

BioProcessing, Inc.

AMPCOR Technologies, Inc.

Laboratory Corporation of America Holdings

American Diagnostica Inc.

GRANT Life Sciences, Inc.

Luminex Corporation

Akonni Biosystems Inc

Progentech USA, Inc.

Source MDx For more information, please visit :

http://www.aarkstore.com/reports/United-States-In-Vitro-Diagnostics-Investment-Opportunities-Analysis-and-Forecasts-to-2015-8416.html

Or email us at press@aarkstore.com or call +919272852585About the Author:

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)